Smirnova I V, Vamos S, Wiegmann T, Citron B A, Arnold P M, Festoff B W
Fluorescence Imaging Laboratories Department of Veterans Affairs Medical Center, Kansas City, MO 64128, USA.
J Mol Neurosci. 1998 Feb;10(1):31-44. doi: 10.1007/BF02737083.
Thrombin, the ultimate enzyme in the blood coagulation cascade, has prominent actions on various cells, including neurons. As in platelets, thrombin increases [Ca2+]i mobilization in neurons, and also retracts neurites. Both these effects are mediated through a G protein-coupled, proteolytically activated receptor for thrombin (PAR-1). Prolonged exposure to thrombin kills neurons via apoptosis, that may also involve PAR-1 activation. Increased [Ca2+]i has been a unifying mechanism proposed for cell death in several neurodegenerative diseases. Thrombin-elevated calcium levels may activate intracellular cascades in neurons leading to cell death. Since thrombin mediates its diverse effects on cells through both heterotrimeric and monomeric G proteins, we also explored what effect altering differential G protein coupling would have on the neuronal response to thrombin. We studied calcium mobilization by thrombin in a model motor neuronal cell line, NSC19, using fluorescence image analysis. Confirming effects in other neuronal types, thrombin caused dramatic increases in [Ca2+]i levels, both transiently and after prolonged exposure, which involved activation and cleavage of the PAR-1 receptor. Using enzyme linked immunosorbent assay (ELISA) and dot-blot analysis, we found that the N-terminal fragment of PAR-1 was released into the medium after exposure to thrombin. We confirmed that PAR-1 protein and mRNA expression occurred in motor neurons. We found that cholera toxin inhibited thrombin-mediated Ca2+ influx, pertussis toxin did not significantly alter thrombin action, and lovastatin, a small 21-kDa Ras GTPase (Rho) modulator, showed a tendency to reduce the thrombin effect. These data indicate that thrombin-increased [Ca2+]i, sufficient to trigger cell death in motor neurons, might be approached in vivo by modulating thrombin signaling through PAR-1.
凝血酶是血液凝固级联反应中的最终酶,对包括神经元在内的各种细胞具有显著作用。与在血小板中一样,凝血酶可增加神经元内的[Ca2+]i动员,并使神经突回缩。这两种效应均通过凝血酶的G蛋白偶联、蛋白水解激活受体(PAR-1)介导。长时间暴露于凝血酶会通过凋亡杀死神经元,这也可能涉及PAR-1激活。[Ca2+]i升高是几种神经退行性疾病中提出的细胞死亡统一机制。凝血酶升高的钙水平可能激活神经元内的级联反应,导致细胞死亡。由于凝血酶通过异三聚体和单体G蛋白介导其对细胞的多种作用,我们还探讨了改变不同G蛋白偶联对神经元对凝血酶反应的影响。我们使用荧光图像分析,在模型运动神经元细胞系NSC19中研究了凝血酶引起的钙动员。与在其他神经元类型中的作用一致,凝血酶导致[Ca2+]i水平急剧升高,无论是短暂升高还是长时间暴露后升高,这涉及PAR-1受体的激活和裂解。使用酶联免疫吸附测定(ELISA)和斑点印迹分析,我们发现PAR-1的N端片段在暴露于凝血酶后释放到培养基中。我们证实PAR-1蛋白和mRNA表达存在于运动神经元中。我们发现霍乱毒素抑制凝血酶介导的Ca2+内流,百日咳毒素未显著改变凝血酶的作用,而21 kDa的小Ras GTP酶(Rho)调节剂洛伐他汀显示出降低凝血酶作用的趋势。这些数据表明,凝血酶升高的[Ca2+]i足以触发运动神经元的细胞死亡,在体内可能通过调节PAR-1的凝血酶信号传导来实现。